a2 Milk, Bright Dairy and Hangzhou Pupai release group standard for A1/A2 beta-casein testing

a2 Milk, Bright Dairy and Hangzhou Pupai release group standard for A1/A2 beta-casein testing

Summary

a2 Milk Company, Bright Dairy and Hangzhou Pupai jointly released a group standard, T/CNHFA 233-2026, at the 2026 Special Food Conference on 16 November 2026. The standard, Determination of A1 and A2 beta-casein in milk and dairy products and infant formula by liquid chromatography-tandem mass spectrometry, uses absolute quantitative LC-MS/MS to quantify A1, A2 and type I beta-casein variants. Inter-laboratory validation has been completed at five institutions, including the Technical Centre for Animal, Plant and Food Inspection and Quarantine of Shanghai Customs.

The standard aims to advance scientific and precise testing of A1/A2 beta-casein and provide a unified method for quantifying protein variants in milk, dairy products and infant formula.

Commentary

The release of the A1/A2 beta-casein testing group standard by a2 Milk, Bright Dairy and others marks the entry of the A2 protein category into a standardised phase in the China market. a2 Milk, a global pioneer in A2 protein dairy, derives more than half its revenue from Greater China, while Bright Dairy is one of China's dairy majors. Their joint development of the standard reflects both the responsibility of industry leaders and the shift of the A2 protein market from a marketing concept to scientific validation.

For New Zealand small and medium-sized business owners, the standard may have a two-fold impact. On one hand, a unified testing method helps regulate the market, reduce misuse of the A2 concept by inferior products and protect companies genuinely developing A2 protein products. On the other hand, because Chinese companies led the standard's development, it may raise technical barriers.

New Zealand small and medium-sized dairy firms seeking to enter the China market will need to ensure their products comply and may need testing at China-recognised laboratories, adding compliance costs. In industry terms, the global A2 protein dairy market has grown rapidly in recent years, with China one of the main consumer markets, but a unified testing standard had been lacking, leaving the market mixed. As a major dairy exporter, New Zealand has seen large companies such as Fonterra launch A2 products, while smaller firms rely more on differentiated competition.

Implementation of the standard may accelerate industry consolidation, giving an edge to companies with testing capability and brand credibility. In addition, the standard's use of LC-MS/MS sets a relatively high technical threshold. New Zealand small and medium-sized firms should monitor testing costs and turnaround times, and consider building links with Chinese partners to reduce market-access difficulty.

Keywords: a2 Milk Company, Bright Dairy, beta-casein, group standard, liquid chromatography-mass spectrometry, infant formula, Special Food Conference, Hangzhou Pupai, inter-laboratory validation


AI illustration on MiDeer Observer

Source: MYFNB

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *